S J O Veldhuyzen van Zanten

Summary

Affiliation: Dalhousie University
Country: Canada

Publications

  1. ncbi request reprint The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology
    S J Van Zanten
    Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia
    Gastroenterology 116:1217-29. 1999
  2. pmc Recurrent diarrhoea and weight loss associated with cessation of smoking in a patient with undiagnosed coeliac disease
    S J Veldhuyzen van Zanten
    Dalhousie University, Department of Medicine, Queen Elizabeth II Health Sciences Center, Room 928, Centennial Building, 1278 Tower Road, Halifax, NS B3H 2Y9, Canada
    Gut 49:588. 2001
  3. pmc Helicobacter pylori: new developments and treatments
    S J Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS
    CMAJ 156:1565-74. 1997
  4. pmc Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Victoria General Site, Room 928 Centennial Building, 5790 University Avenue, Halifax, Nova Scotia, Canada B3H 2YG, Canada
    Gut 50:iv26-30; discussion iv31-2. 2002
  5. pmc Assessment of outcome in dyspepsia: has progress been made?
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Victoria General Site, Room 928 Centennial Building, 5790 University Avenue, Halifax, Nova Scotia, Canada B3H 2YG, Canada
    Gut 50:iv23-5. 2002
  6. pmc Design of treatment trials for functional gastrointestinal disorders
    S J Veldhuyzen van Zanten
    Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders Rome II, Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
    Gut 45:II69-77. 1999
  7. ncbi request reprint Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:521-9. 2006
  8. ncbi request reprint The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:595-9. 2006
  9. ncbi request reprint Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study
    D Armstrong
    Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
    Aliment Pharmacol Ther 21:1189-202. 2005
  10. pmc Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods
    L M Best
    Queen Elizabeth II Center for Clinical Research, Halifax, Canada
    Antimicrob Agents Chemother 47:3138-44. 2003

Detail Information

Publications11

  1. ncbi request reprint The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology
    S J Van Zanten
    Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia
    Gastroenterology 116:1217-29. 1999
    ..This review also explains that diffuse antral gastritis and multifocal atrophic gastritis are part of the same disease and not separate entities...
  2. pmc Recurrent diarrhoea and weight loss associated with cessation of smoking in a patient with undiagnosed coeliac disease
    S J Veldhuyzen van Zanten
    Dalhousie University, Department of Medicine, Queen Elizabeth II Health Sciences Center, Room 928, Centennial Building, 1278 Tower Road, Halifax, NS B3H 2Y9, Canada
    Gut 49:588. 2001
  3. pmc Helicobacter pylori: new developments and treatments
    S J Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS
    CMAJ 156:1565-74. 1997
    ....
  4. pmc Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Victoria General Site, Room 928 Centennial Building, 5790 University Avenue, Halifax, Nova Scotia, Canada B3H 2YG, Canada
    Gut 50:iv26-30; discussion iv31-2. 2002
    ..Recently, two very similar studies, the ORCHID and OCAY studies, have been completed and the combined results of these two multicentre, multinational, randomised, double blind, controlled clinical trials are reviewed...
  5. pmc Assessment of outcome in dyspepsia: has progress been made?
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Victoria General Site, Room 928 Centennial Building, 5790 University Avenue, Halifax, Nova Scotia, Canada B3H 2YG, Canada
    Gut 50:iv23-5. 2002
    ..Recently, a few validated outcome measures have been developed which look promising...
  6. pmc Design of treatment trials for functional gastrointestinal disorders
    S J Veldhuyzen van Zanten
    Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders Rome II, Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
    Gut 45:II69-77. 1999
    ..In this report, guidelines are given for the basic architecture of intervention studies of FGIDs. Further studies on design issues are required to ensure the recommendations will become evidence based in the future...
  7. ncbi request reprint Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:521-9. 2006
    ..Currently there is no consensus on the optimal method to measure the severity of dyspepsia symptoms in clinical trials...
  8. ncbi request reprint The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:595-9. 2006
    ..The prevalence of Barrett's oesophagus in patients undergoing gastroscopy may be influenced by possible referral bias...
  9. ncbi request reprint Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study
    D Armstrong
    Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
    Aliment Pharmacol Ther 21:1189-202. 2005
    ..There are few data on empiric, stepped therapy for heartburn relief or subsequent relapse in primary care...
  10. pmc Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods
    L M Best
    Queen Elizabeth II Center for Clinical Research, Halifax, Canada
    Antimicrob Agents Chemother 47:3138-44. 2003
    ..pylori 93% of the time by either the agar dilution or E test method, and the numbers of errors were relatively equivalent by both methods...
  11. pmc Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile
    D E Mahony
    Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7
    Antimicrob Agents Chemother 49:431-3. 2005
    ..Using mass spectrometry and the agar dilution method, we determined that insoluble BSS interacts with certain dietary components and organic substrates to produce water-soluble products with activity against Clostridium difficile...